Butazolidin Injectable 20 Patent Expiration

About Butazolidin Injectable 20

Butazolidin Injectable 20 is a drug owned by INTERVET, INC. Butazolidin Injectable 20 uses Phenylbutazone as the active ingredient.

Active Ingredient:

Butazolidin Injectable 20 uses Phenylbutazone as the active ingredient. Check out other Drugs and Companies using Phenylbutazone ingredient.